EPISODE · Aug 10, 2026 · 12 MIN
Why P&G Just Acquired Thorne for $3.8 Billion | Will Procter & Gamble Dilute Thorne Supplements?
from the Joshua Schall Audio Experience · host Joshua Schall
Procter & Gamble just dropped a staggering $3.8 billion to acquire Thorne, leaving mainstream financial commentators and health enthusiasts completely shocked. Why would a consumer packaged goods (CPG) titan known for Pampers, Tide, and Crest buy a premium dietary supplement brand? In this video, I'll pull back the curtain on the financial architecture and the radical corporate strategy driving this massive M&A transaction. This is far from just selling vitamins...creating a massive strategic paradigm shift into AI-powered predictive health, longevity, and data-rich consumer ecosystems. I'm breaking down the private equity wins for L Catterton, Thorne’s massive manufacturing and testing moats, and how P&G completely outmaneuvered rivals like Unilever and Haleon to dominate the healthcare practitioner market. Plus, we address the biggest question on every consumer's mind: Will P&G dilute Thorne's ingredients and destroy its scientific integrity? If you want to understand the future of proactive, personalized, and integrative consumer healthcare, this deep dive is for you.
Embed this episode
NOW PLAYING
Why P&G Just Acquired Thorne for $3.8 Billion | Will Procter & Gamble Dilute Thorne Supplements?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.